Trial Profile
Study of olaparib in ovarian cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2018
Price :
$35
*
At a glance
- Drugs Olaparib (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 03 Dec 2018 New trial record
- 16 Nov 2018 Results published in the Targeted Oncology